394 related articles for article (PubMed ID: 6730614)
1. [Vital microscopy of nailfold capillaries in progressive scleroderma in relation to the clinical picture].
Arizpe SR; Hornstein OP; Deinlein E
Z Hautkr; 1984 May; 59(9):593-600. PubMed ID: 6730614
[TBL] [Abstract][Full Text] [Related]
2. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.
Lee P; Sarkozi J; Bookman AA; Keystone EC; Armstrong SK
J Rheumatol; 1986 Jun; 13(3):564-9. PubMed ID: 3735278
[TBL] [Abstract][Full Text] [Related]
3. Relationship between nailfold capillary microscopy and salivary capillary basement membrane width in Raynaud's disease and progressive systemic sclerosis.
DeBure C; Fiessinger JN; Priollet P; Camilleri JP; Vayssairat M; Kazandjian S; Housset E
J Rheumatol; 1985 Apr; 12(2):279-82. PubMed ID: 4032402
[TBL] [Abstract][Full Text] [Related]
4. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment.
Lee P; Leung FY; Alderdice C; Armstrong SK
J Rheumatol; 1983 Dec; 10(6):930-8. PubMed ID: 6663597
[TBL] [Abstract][Full Text] [Related]
5. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome.
Statham BN; Rowell NR
Acta Derm Venereol; 1986; 66(2):139-43. PubMed ID: 2424237
[TBL] [Abstract][Full Text] [Related]
6. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
Maricq HR
Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
[TBL] [Abstract][Full Text] [Related]
7. Raynaud's phenomenon in mixed connective tissue disease.
Grader-Beck T; Wigley FM
Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
Houtman PM; Kallenberg CG; Fidler V; Wouda AA
J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
[TBL] [Abstract][Full Text] [Related]
9. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
Navon P; Yarom A; Davis E
J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
[TBL] [Abstract][Full Text] [Related]
10. [Capillaroscopy and Raynaud's phenomenon].
Carpentier P; Franco A
J Mal Vasc; 1984; 9(1):23-8. PubMed ID: 6707531
[TBL] [Abstract][Full Text] [Related]
11. Nailfold capillaroscopy in connective tissue disorders and in Raynaud's phenomenon.
Blockmans D; Vermylen J; Bobbaers H
Acta Clin Belg; 1993; 48(1):30-41. PubMed ID: 8388601
[TBL] [Abstract][Full Text] [Related]
12. Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.
Wildt M; Hesselstrand R; Akesson A; Scheja A
Scand J Rheumatol; 2007; 36(6):452-7. PubMed ID: 18092267
[TBL] [Abstract][Full Text] [Related]
13. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
[TBL] [Abstract][Full Text] [Related]
14. Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma.
ter Borg EJ; Piersma-Wichers G; Smit AJ; Kallenberg CG; Wouda AA
Semin Arthritis Rheum; 1994 Aug; 24(1):40-7. PubMed ID: 7985036
[TBL] [Abstract][Full Text] [Related]
15. Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease.
Pallis M; Hopkinson N; Powell R
J Rheumatol; 1991 Oct; 18(10):1532-6. PubMed ID: 1765978
[TBL] [Abstract][Full Text] [Related]
16. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
[TBL] [Abstract][Full Text] [Related]
17. Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon.
Beltrán E; Toll A; Pros A; Carbonell J; Pujol RM
Br J Dermatol; 2007 May; 156(5):892-8. PubMed ID: 17388920
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
[TBL] [Abstract][Full Text] [Related]
20. Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy.
Akay BN; Sanli H; Topcuoglu P; Arat M; Akyol A
Br J Dermatol; 2010 May; 162(5):1076-82. PubMed ID: 20222922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
